These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32606364)

  • 1. In vivo stem cell tracking using scintigraphy in a canine model of DMD.
    Barthélémy I; Thibaud JL; de Fornel P; Cassano M; Punzón I; Mauduit D; Vilquin JT; Devauchelle P; Sampaolesi M; Blot S
    Sci Rep; 2020 Jun; 10(1):10681. PubMed ID: 32606364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
    Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
    Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.
    Robriquet F; Babarit C; Larcher T; Dubreil L; Ledevin M; Goubin H; Rouger K; Guével L
    BMC Musculoskelet Disord; 2016 May; 17():209. PubMed ID: 27170302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscular dystrophy in a dog resembling human becker muscular dystrophy.
    Baroncelli AB; Abellonio F; Pagano TB; Esposito I; Peirone B; Papparella S; Paciello O
    J Comp Pathol; 2014 May; 150(4):429-33. PubMed ID: 24529507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The golden retriever model of Duchenne muscular dystrophy.
    Kornegay JN
    Skelet Muscle; 2017 May; 7(1):9. PubMed ID: 28526070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.
    Terrill JR; Duong MN; Turner R; Le Guiner C; Boyatzis A; Kettle AJ; Grounds MD; Arthur PG
    Redox Biol; 2016 Oct; 9():276-286. PubMed ID: 27611888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of cardiac progenitor cell potency in GRMD dogs.
    Cassano M; Berardi E; Crippa S; Toelen J; Barthelemy I; Micheletti R; Chuah M; Vandendriessche T; Debyser Z; Blot S; Sampaolesi M
    Cell Transplant; 2012; 21(9):1945-67. PubMed ID: 22513051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin.
    Vieira NM; Valadares M; Zucconi E; Secco M; Bueno CR; Brandalise V; Assoni A; Gomes J; Landini V; Andrade T; Caetano HV; Vainzof M; Zatz M
    Cell Transplant; 2012; 21(7):1407-17. PubMed ID: 23168016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
    Le Guiner C; Servais L; Montus M; Larcher T; Fraysse B; Moullec S; Allais M; François V; Dutilleul M; Malerba A; Koo T; Thibaut JL; Matot B; Devaux M; Le Duff J; Deschamps JY; Barthelemy I; Blot S; Testault I; Wahbi K; Ederhy S; Martin S; Veron P; Georger C; Athanasopoulos T; Masurier C; Mingozzi F; Carlier P; Gjata B; Hogrel JY; Adjali O; Mavilio F; Voit T; Moullier P; Dickson G
    Nat Commun; 2017 Jul; 8():16105. PubMed ID: 28742067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A computerized MRI biomarker quantification scheme for a canine model of Duchenne muscular dystrophy.
    Wang J; Fan Z; Vandenborne K; Walter G; Shiloh-Malawsky Y; An H; Kornegay JN; Styner MA
    Int J Comput Assist Radiol Surg; 2013 Sep; 8(5):763-74. PubMed ID: 23299128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
    Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
    Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy.
    Schneider SM; Sridhar V; Bettis AK; Heath-Barnett H; Balog-Alvarez CJ; Guo LJ; Johnson R; Jaques S; Vitha S; Glowcwski AC; Kornegay JN; Nghiem PP
    Mol Imaging Biol; 2018 Oct; 20(5):780-788. PubMed ID: 29508262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog.
    Zucconi E; Valadares MC; Vieira NM; Bueno CR; Secco M; Jazedje T; da Silva HC; Vainzof M; Zatz M
    Neuromuscul Disord; 2010 Jan; 20(1):64-70. PubMed ID: 19944604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
    Yuasa K; Nakamura A; Hijikata T; Takeda S
    BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Muscle Metabolism are Associated with Phenotypic Variability in Golden Retriever Muscular Dystrophy.
    Nghiem PP; Bello L; Stoughton WB; López SM; Vidal AH; Hernandez BV; Hulbert KN; Gourley TR; Bettis AK; Balog-Alvarez CJ; Heath-Barnett H; Kornegay JN
    Yale J Biol Med; 2017 Sep; 90(3):351-360. PubMed ID: 28955176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells.
    Lardenois A; Jagot S; Lagarrigue M; Guével B; Ledevin M; Larcher T; Dubreil L; Pineau C; Rouger K; Guével L
    Proteomics; 2016 Jul; 16(14):2028-42. PubMed ID: 27246553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of disease severity in a Canine Model of Duchenne Muscular Dystrophy: Classification of Quantitative MRI.
    Eresen A; Alic L; Kornegay J; Ji JX
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():648-651. PubMed ID: 30440480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle percentage index as a marker of disease severity in golden retriever muscular dystrophy.
    Eresen A; Hafsa NE; Alic L; Birch SM; Griffin JF; Kornegay JN; Ji JX
    Muscle Nerve; 2019 Nov; 60(5):621-628. PubMed ID: 31397906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.